alprenolol has been researched along with h 89 in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M | 1 |
| Andreis, PG; Aragona, F; De Caro, R; Gottardo, L; Mazzocchi, G; Nussdorfer, GG | 1 |
| Agulló, L; Garcia-Dorado, D; Inserte, J; Pina, P; Ruiz-Meana, M; Soler-Soler, J | 1 |
3 other study(ies) available for alprenolol and h 89
| Article | Year |
|---|---|
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries | 2023 |
Cerebellin enhances in vitro secretory activity of human adrenal gland.
Topics: Adrenal Cortex; Adrenal Glands; Adrenal Medulla; Adrenergic alpha-Antagonists; Adult; Aldosterone; Alprenolol; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Enzyme Inhibitors; Epinephrine; Humans; Hydrocortisone; In Vitro Techniques; Isoquinolines; Nerve Tissue Proteins; Norepinephrine; Sulfonamides | 1999 |
Ischemic preconditioning attenuates calpain-mediated degradation of structural proteins through a protein kinase A-dependent mechanism.
Topics: Adrenergic beta-Antagonists; Alprenolol; Animals; Calpain; Carrier Proteins; Cyclic AMP-Dependent Protein Kinases; Dipeptides; Enzyme Activation; Ischemic Preconditioning, Myocardial; Isoquinolines; L-Lactate Dehydrogenase; Male; Membrane Proteins; Microfilament Proteins; Myocardial Reperfusion Injury; Myocardium; Naloxone; Narcotic Antagonists; Necrosis; Perfusion; Rats; Rats, Sprague-Dawley; Sodium; Sulfonamides | 2004 |